Home Capital Results

Trendlines’ FY16 losses double to $9.4 mil

Michelle Zhu
Michelle Zhu2/22/2017 08:11 AM GMT+08  • 2 min read
Trendlines’ FY16 losses double to $9.4 mil
SINGAPORE (Feb 22): The Trendlines Group, an Israeli-based company focused on developing technology-based companies in the medical and agricultural fields, posted full-year loss of US$6.6 million ($9.4 million), double from its loss of US$3.3 million decl
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Feb 22): The Trendlines Group, an Israeli-based company focused on developing technology-based companies in the medical and agricultural fields, posted full-year loss of US$6.6 million ($9.4 million), double from its loss of US$3.3 million declared in the previous year.

For the year ended Dec 31, the group received a total income of US$0.1 million as compared to US$9.9 million in FY15 despite noting a strong rise in revenue from Trendlines Labs to US$1.14 million from US$0.4 million in the previous year.

This was primarily due to a US$8 million loss from the change in the fair value of Trendlines’ portfolio companies during the year, versus a net gain of about $5 million in FY15, which was partially attributable to a write-off of nine portfolio companies due to lack of funding.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.